Pulmatrix
David Denning is an infectious diseases clinician with expertise in fungal diseases. He trained at Guys Hospital, London, and as a young doctor also in London (University College and Northwick Park hospitals), Glasgow, and Stanford, California. He has been researching and caring for patients with aspergillosis since 1985 and retired as a clinician in 2020.
He was the founding Director of the UK’s National Aspergillosis Centre (2009-2020). He has published more than 600 papers and book chapters. He has successfully led many major international collaborative science, diagnostic, and treatment projects and clinical guidelines, with subsequent publication in Nature, the New England Journal of Medicine, and the Lancet. He is heavily involved in postgraduate teaching and lectures worldwide. He was instrumental in the establishment of the Mycology Reference Centre in Manchester (2009), which grew out of the Fungal Testing Laboratory he founded in 1991.
This person is not in the org chart
This person is not in any offices
Pulmatrix
Specialty biotech developing the next generation of inhaled therapies for such conditions as #cysticfibrosis #COPD & idiopathic pulmonary fibrosis.